PRTK – Paratek Pharmaceuticals, Inc. – Nasdaq

  • Quotes
  • Charts

News & Analysis for PRTK

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Entry into a Material...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Entry into a Material...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Other Events

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Entry into a Material...

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...

ME Staff 8-k - 0

Analyst Activity – HC Wainwright Raises Its Price Target On Paratek...

ME Staff - 0

Biotech Movers: Paratek Pharmaceuticals Inc (NASDAQ:PRTK), Intra-Cellular Therapies Inc (NASDAQ:ITCI) and...

- 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Departure of Directors or...

ME Staff 8-k - 0

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) Announces Successful Phase 3 trials For Omadacycline

Andy Parker - 0

Analyst Activity – HC Wainwright Raises Its Price Target On Paratek...

ME Staff - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Regulation FD Disclosure

ME Staff 8-k - 0

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Entry into a Material...

ME Staff 8-k - 0
Load more